Old Web
English
Sign In
Acemap
>
authorDetail
>
Xue-Ning Yang
Xue-Ning Yang
Peking Union Medical College
Medicine
Internal medicine
Oncology
Lung cancer
Proportional hazards model
5
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report.
2021
Clinical Drug Investigation
Hai-Yan Tu
Yang-Si Li
Jin-Ji Yang
Hua-Jun Chen
Ben-Yuan Jiang
Wen-Zhao Zhong
Xue-Ning Yang
Yi-Long Wu
Show All
Source
Cite
Save
Citations (0)
Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients with Lung Adenocarcinoma after Complete Resection: Results From the ICAN Study
2021
Xue-Ning Yang
Hong-Hong Yan
Jun Wang
Xiang-Yang Chu
Zhidong Liu
Yi Shen
Haitao Ma
Xiangning Fu
Jian Hu
Nai-Kang Zhou
Yongyu Liu
Xinming Zhou
Jing-Song Li
Kang Yang
Jian Li
Lin Xu
Siyu Wang
Qun Wang
Lunxu Liu
Shun Xu
Zhong-Yuan Chen
Hong-He Lou
Changli Wang
Ying Cheng
Si-Yang Liu
Xu-Chao Zhang
Wen-Zhao Zhong
Yi-Long Wu
Show All
Source
Cite
Save
Citations (0)
Risk Factors of Brain Metastases in IIIA-N2 Non-Small Cell Lung Cancer After Complete Resection.
2021
International Journal of Radiation Oncology Biology Physics
S. Sun
Yu Men
Xue-Ning Yang
Xing Guo Sun
M. Zhao
M. Yuan
Y. Bao
Zeliang Ma
Y.P. Liu
Z. Hui
Show All
Source
Cite
Save
Citations (0)
CTONG1103: Final overall survival analysis of the randomized phase 2 trial of erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non–small cell lung cancer.
2021
Journal of Clinical Oncology
Yi-Long Wu
Wen-Zhao Zhong
Keneng Chen
Chun Chen
Fan Yang
Xue-Ning Yang
Chun-Dong Gu
Weimin Mao
Qun Wang
Gui-Bin Qiao
Ying Cheng
Lin Xu
Changli Wang
Mingwei Chen
Hong-Hong Yan
Ri-Qiang Liao
Xu-Chao Zhang
Jin-Ji Yang
Si-Yang Liu
Qing Zhou
Show All
Source
Cite
Save
Citations (5)
Adjuvant Radiotherapy is Safe and Effective for Patients with T1b-SM2 Esophageal Carcinoma After Endoscopic Resection - A Second Analysis From a Pilot Study.
2021
International Journal of Radiation Oncology Biology Physics
Xue-Ning Yang
Yu Men
J Wang
J Kang
Xing Guo Sun
M. Zhao
S. Sun
M. Yuan
Y. Bao
Zeliang Ma
Gui-Qian Wang
Z. Hui
Show All
Source
Cite
Save
Citations (0)
1